The Medicines Company Slashes Hundreds of Jobs in Restructuring Post author:Sam Post published:October 24, 2017 Post category:BioPharma In addition to the layoffs, the company is also looking to divest its Infectious Disease Business. Source: BioSpace You Might Also Like Spark's Good Week Continues With Signing of Huge Lease Near HQ December 7, 2017 Acadia Scraps a Phase II Alzheimer's Trial, Gets Breakthrough Tag for Dementia-Related Drug October 4, 2017 Lupin Coughs Up $150 Million Cash for This New Jersey-Based Biopharma October 10, 2017
Acadia Scraps a Phase II Alzheimer's Trial, Gets Breakthrough Tag for Dementia-Related Drug October 4, 2017